IL-21-induced MHC class II+ NK cells promote the expansion of human uncommitted CD4+ central memory T cells in a macrophage migration inhibitory factor-dependent manner

Journal of Immunology

Volumn 197, Issue 1, 2016, Pages 85-96

  Loyon, Romain ^a   Picard, Emilie ^a   Mauvais, Olivier ^b   Queiroz, Lise ^a,c   Mougey, Virginie ^a,d   Pallandre, Jean René ^a,e   Galaine, Jeanne ^a   Mercier Letondal, Patricia ^a,d   Kellerman, Guillaume ^e   Chaput, Nathalie ^e   Wijdenes, John ^a   Adotévi, Olivier ^a,b,c   Ferrand, Christophe ^a,d   Romero, Pedro ^f   Godet, Yann ^a   Borg, Christophe ^a,b,c,d  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c Clinical Investigation Center   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e INSERM   (France)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; INTERLEUKIN DERIVATIVE; ISOMERASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MIF PROTEIN, HUMAN;

ANTIGEN EXPRESSION; APPENDICITIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CROSS PRESENTATION; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE MIGRATION INHIBITION; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOTOXICITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; METABOLISM; TH1 CELL; TONSILLITIS;

ANTIGENS, CD86; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HLA-DR ANTIGENS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERLEUKINS; INTRAMOLECULAR OXIDOREDUCTASES; KILLER CELLS, NATURAL; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; TH1 CELLS; TONSILLITIS;

EID: 84975231577     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501147     Document Type: Article

References (62)

1. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
2. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
3. Lee, S.-H., T. Miyagi, and C. A. Biron. 2007. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28: 252-259.
4. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-g production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156: 1138-1142.
5. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-ab, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.
6. Chaigne-Delalande, B., F.-Y. Li, G. M. O'Connor, M. J. Lukacs, P. Jiang, L. Zheng, A. Shatzer, M. Biancalana, S. Pittaluga, H. F. Matthews, et al. 2013. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 341: 186-191.
7. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Naturalkiller cells and dendritic cells: "l'union fait la force". Blood 106: 2252-2258.
8. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
9. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351.
10. Borg, C., A. Jalil, D. Laderach, K. Maruyama, H. Wakasugi, S. Charrier, B. Ryffel, A. Cambi, C. Figdor, W. Vainchenker, et al. 2004. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267-3275.
11. Martín-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-g for TH1 priming. Nat. Immunol. 5: 1260-1265.
12. Bajénoff, M., B. Breart, A. Y. C. Huang, H. Qi, J. Cazareth, V. M. Braud, R. N. Germain, and N. Glaichenhaus. 2006. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203: 619-631.
13. Schleicher,U., J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A. A. Fischer, S. Weiss, U. Kalinke, S. Kunz, and C. Bogdan. 2007. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J. Exp. Med. 204: 893-906.
14. Laouar, Y., F. S. Sutterwala, L. Gorelik, and R. A. Flavell. 2005. Transforming growth factor-b controls T helper type 1 cell development through regulation of natural killer cell interferon-g. Nat. Immunol. 6: 600-607.
15. Cameron, A. L., B. Kirby, W. Fei, and C. E. M. Griffiths. 2002. Natural killer and natural killer-T cells in psoriasis. Arch. Dermatol. Res. 294: 363-369.
16. Delahaye, N. F., S. Rusakiewicz, I. Martins, C. Ménard, S. Roux, L. Lyonnet, P. Paul, M. Sarabi, N. Chaput, M. Semeraro, et al. 2011. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat. Med. 17: 700-707.
17. Rusakiewicz, S., G. Nocturne, T. Lazure, M. Semeraro, C. Flament, S. Caillat-Zucman, D. Sène, N. Delahaye, E. Vivier, K. Chaba, et al. 2013. NCR3/NKp30 contributes to pathogenesis in primary Sjögren's syndrome. Sci. Transl. Med. 5: 195ra96.
18. Liu, R., Y. Bai, T. L. Vollmer, X.-F. Bai, Y. Jee, Y. Y. Tang, D. I. Campagnolo, M. Collins, D. A. Young, A. La Cava, and F.-D. Shi. 2008. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Exp. Neurol. 211: 14-24.
19. Vollmer, T. L., R. Liu, M. Price, S. Rhodes, A. La Cava, and F.-D. Shi. 2005. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 174: 2696-2701.
20. Elsaesser, H., K. Sauer, and D. G. Brooks. 2009. IL-21 is required to control chronic viral infection. Science 324: 1569-1572.
21. Cavazzana-Calvo, M., S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. L. Casanova, et al. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672.
22. Lieberman, L. A., and G. C. Tsokos. 2010. The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J. Biomed. Biotechnol. 2010: 740619.
23. Leonard, W. J., and R. Spolski. 2005. Interleukin-21: A modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5: 688-698.
24. Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
25. Meguro, A., K. Ozaki, I. Oh, K. Hatanaka, H. Matsu, R. Tatara, K. Sato, W. J. Leonard, and K. Ozawa. 2010. IL-21 is critical for GVHD in a mouse model. Bone Marrow Transplant. 45: 723-729.
26. Hippen, K. L., C. Bucher, D. K. Schirm, A. M. Bearl, T. Brender, K. A. Mink, K. S. Waggie, R. Peffault de Latour, A. Janin, J. M. Curtsinger, et al. 2012. Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood 119: 619-628.
27. Herber, D., T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178: 3822-3830.
28. Young, D. A., M. Hegen, H. L. M. Ma, M. J. Whitters, L. M. Albert, L. Lowe, M. Senices, P. W. Wu, B. Sibley, Y. Leathurby, et al. 2007. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 56: 1152-1163.
29. Brady, J., Y. Hayakawa, M. J. Smyth, and S. L. Nutt. 2004. IL-21 induces the functional maturation of murine NK cells. J. Immunol. 172: 2048-2058.
30. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22: 633-640.
31. Farag, S. S., and M. A. Caligiuri. 2006. Human natural killer cell development and biology. Blood Rev. 20: 123-137.
32. Gattinoni, L., and N. P. Restifo. 2013. Moving T memory stem cells to the clinic. Blood 121: 567-568.
33. Mahnke, Y. D., T. M. Brodie, F. Sallusto, M. Roederer, and E. Lugli. 2013. The who's who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 43: 2797-2809.
34. Vosshenrich, C. A. J., T. Ranson, S. I. Samson, E. Corcuff, F. Colucci, E. E. Rosmaraki, and J. P. Di Santo. 2005. Roles for common cytokine receptor g-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 174: 1213-1221.
35. Phillips, J. H., A. M. Le, and L. L. Lanier. 1984. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J. Exp. Med. 159: 993-1008.
36. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301-331.
37. Roncarolo, M. G., M. Bigler, J. B. Haanen, H. Yssel, R. Bacchetta, J. E. de Vries, and H. Spits. 1991. Natural killer cell clones can efficiently process and present protein antigens. J. Immunol. 147: 781-787.
38. Kim, M., N. R. Osborne, W. Zeng, H. Donaghy, K. McKinnon, D. C. Jackson, and A. L. Cunningham. 2012. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. J. Immunol. 188: 4158-4170.
39. Zingoni, A., T. Sornasse, B. G. Cocks, Y. Tanaka, A. Santoni, and L. L. Lanier. 2004. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J. Immunol. 173: 3716-3724.
40. Skak, K., K. S. Frederiksen, and D. Lundsgaard. 2008. Interleukin-21 activates human natural killer cells and modulates their surface receptor expression. Immunology 123: 575-583.
41. Li, W., D. M. Janowicz, K. R. Fortney, B. P. Katz, and S. M. Spinola. 2009. Mechanism of human natural killer cell activation by Haemophilus ducreyi. J. Infect. Dis. 200: 590-598.
42. Evans, J. H., A. Horowitz, M. Mehrabi, E. L. Wise, J. E. Pease, E. M. Riley, and D. M. Davis. 2011. A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur. J. Immunol. 41: 1924-1933.
43. Rubér, M., M. Andersson, B. F. Petersson, G. Olaison, R. E. Andersson, and C. Ekerfelt. 2010. Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis. Surgery 147: 366-372.
44. Fehniger, T. A., M. A. Cooper, G. J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M. A. Caligiuri. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
45. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W. A. Muller, L. Moretta, and C. Munz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101: 16606-16611.
46. Kassim, S. H., N. K. Rajasagi, X. Zhao, R. Chervenak, and S. R. Jennings. 2006. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J. Virol. 80: 3985-3993.
47. Barr, D. P., G. T. Belz, P. C. Reading, M. Wojtasiak, P. G. Whitney, W. R. Heath, F. R. Carbone, and A. G. Brooks. 2007. A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur. J. Immunol. 37: 1334-1342.
48. Mailliard, R. B., S. M. Alber, H. Shen, S. C. Watkins, J. M. Kirkwood, R. B. Herberman, and P. Kalinski. 2005. IL-18-induced CD83+CCR7+ NK helper cells. J. Exp. Med. 202: 941-953.
49. Eisenring, M., J. vom Berg, G. Kristiansen, E. Saller, and B. Becher. 2010. IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat. Immunol. 11: 1030-1038.
50. Ji, Y., X. Yang, J. Li, Z. Lu, X. Li, J. Yu, and N. Li. 2014. IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling. Int. J. Clin. Exp. Pathol. 7: 3694-3703.
51. Kryczek, I., Y. Lin, N. Nagarsheth, D. Peng, L. Zhao, E. Zhao, L. Vatan, W. Szeliga, Y. Dou, S. Owens, et al. 2014. IL-22+CD4+ T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity 40: 772-784.
52. Kirchberger, S., D. J. Royston, O. Boulard, E. Thornton, F. Franchini, R. L. Szabady, O. Harrison, and F. Powrie. 2013. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210: 917-931.
53. Hepworth, M. R., L. A. Monticelli, T. C. Fung, C. G. K. Ziegler, S. Grunberg, R. Sinha, A. R. Mantegazza, H.-L. Ma, A. Crawford, J. M. Angelosanto, et al. 2013. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498: 113-117.
54. Mirchandani, A. S., A.-G. Besnard, E. Yip, C. Scott, C. C. Bain, V. Cerovic, R. J. Salmond, and F. Y. Liew. 2014. Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J. Immunol. 192: 2442-2448.
55. von Burg, N., S. Chappaz, A. Baerenwaldt, E. Horvath, S. Bose Dasgupta, D. Ashok, J. Pieters, F. Tacchini-Cottier, A. Rolink, H. Acha-Orbea, and D. Finke. 2014. Activated group 3 innate lymphoid cells promote T-cellmediated immune responses. Proc. Natl. Acad. Sci. USA 111: 12835-12840.
56. Lue, H., A. Kapurniotu, G. Fingerle-Rowson, T. Roger, L. Leng, M. Thiele, T. Calandra, R. Bucala, and J. Bernhagen. 2006. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell. Signal. 18: 688-703.
57. Lue, H., M. Thiele, J. Franz, E. Dahl, S. Speckgens, L. Leng, G. Fingerle-Rowson, R. Bucala, B. Luscher, and J. Bernhagen. 2007. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26: 5046-5059.
58. Starlets, D., Y. Gore, I. Binsky, M. Haran, N. Harpaz, L. Shvidel, S. Becker-Herman, A. Berrebi, and I. Shachar. 2006. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107: 4807-4816.
59. Bacher, M., C. N. Metz, T. Calandra, K. Mayer, J. Chesney, M. Lohoff, D. Gemsa, T. Donnelly, and R. Bucala. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA 93: 7849-7854.
60. Langenkamp, A., K. Nagata, K. Murphy, L. Wu, A. Lanzavecchia, and F. Sallusto. 2003. Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur. J. Immunol. 33: 474-482.
61. Rivino, L., M. Messi, D. Jarrossay, A. Lanzavecchia, F. Sallusto, and J. Geginat. 2004. Chemokine receptor expression identifies pre-T helper (Th)1, pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J. Exp. Med. 200: 725-735.
62. Gattinoni, L., E. Lugli, Y. Ji, Z. Pos, C. M. Paulos, M. F. Quigley, J. R. Almeida, E. Gostick, Z. Yu, C. Carpenito, et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17: 1290-1297.